Raphael Pharmaceutical's market value is the price at which a share of Raphael Pharmaceutical trades on a public exchange. It measures the collective expectations of Raphael Pharmaceutical investors about its performance. Raphael Pharmaceutical is trading at 1.40 as of the 29th of December 2025. This is a No Change since the beginning of the trading day. The stock's open price was 1.4. With this module, you can estimate the performance of a buy and hold strategy of Raphael Pharmaceutical and determine expected loss or profit from investing in Raphael Pharmaceutical over a given investment horizon. Check out Raphael Pharmaceutical Correlation, Raphael Pharmaceutical Volatility and Raphael Pharmaceutical Alpha and Beta module to complement your research on Raphael Pharmaceutical.
Please note, there is a significant difference between Raphael Pharmaceutical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Raphael Pharmaceutical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Raphael Pharmaceutical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Raphael Pharmaceutical 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Raphael Pharmaceutical's otc stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Raphael Pharmaceutical.
0.00
11/29/2025
No Change 0.00
0.0
In 31 days
12/29/2025
0.00
If you would invest 0.00 in Raphael Pharmaceutical on November 29, 2025 and sell it all today you would earn a total of 0.00 from holding Raphael Pharmaceutical or generate 0.0% return on investment in Raphael Pharmaceutical over 30 days. Raphael Pharmaceutical is related to or competes with Avicanna, and Mydecine Innovations. More
Raphael Pharmaceutical Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Raphael Pharmaceutical's otc stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Raphael Pharmaceutical upside and downside potential and time the market with a certain degree of confidence.
Today, many novice investors tend to focus exclusively on investment returns with little concern for Raphael Pharmaceutical's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Raphael Pharmaceutical's standard deviation. In reality, there are many statistical measures that can use Raphael Pharmaceutical historical prices to predict the future Raphael Pharmaceutical's volatility.
Raphael Pharmaceutical is out of control given 3 months investment horizon. Raphael Pharmaceutical maintains Sharpe Ratio (i.e., Efficiency) of 0.15, which implies the firm had a 0.15 % return per unit of risk over the last 3 months. We were able to interpolate data for seventeen different technical indicators, which can help you to evaluate if expected returns of 3.26% are justified by taking the suggested risk. Use Raphael Pharmaceutical Coefficient Of Variation of 529.43, risk adjusted performance of 0.1422, and Variance of 554.24 to evaluate company specific risk that cannot be diversified away. Raphael Pharmaceutical holds a performance score of 11 on a scale of zero to a hundred. The company holds a Beta of 0.42, which implies possible diversification benefits within a given portfolio. As returns on the market increase, Raphael Pharmaceutical's returns are expected to increase less than the market. However, during the bear market, the loss of holding Raphael Pharmaceutical is expected to be smaller as well. Use Raphael Pharmaceutical jensen alpha and rate of daily change , to analyze future returns on Raphael Pharmaceutical.
Auto-correlation
0.00
No correlation between past and present
Raphael Pharmaceutical has no correlation between past and present. Overlapping area represents the amount of predictability between Raphael Pharmaceutical time series from 29th of November 2025 to 14th of December 2025 and 14th of December 2025 to 29th of December 2025. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Raphael Pharmaceutical price movement. The serial correlation of 0.0 indicates that just 0.0% of current Raphael Pharmaceutical price fluctuation can be explain by its past prices.
Correlation Coefficient
0.0
Spearman Rank Test
0.68
Residual Average
0.0
Price Variance
0.0
Raphael Pharmaceutical lagged returns against current returns
Autocorrelation, which is Raphael Pharmaceutical otc stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Raphael Pharmaceutical's otc stock expected returns. We can calculate the autocorrelation of Raphael Pharmaceutical returns to help us make a trade decision. For example, suppose you find that Raphael Pharmaceutical has exhibited high autocorrelation historically, and you observe that the otc stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values
Timeline
Raphael Pharmaceutical regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Raphael Pharmaceutical otc stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Raphael Pharmaceutical otc stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Raphael Pharmaceutical otc stock over time.
Current vs Lagged Prices
Timeline
Raphael Pharmaceutical Lagged Returns
When evaluating Raphael Pharmaceutical's market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Raphael Pharmaceutical otc stock have on its future price. Raphael Pharmaceutical autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Raphael Pharmaceutical autocorrelation shows the relationship between Raphael Pharmaceutical otc stock current value and its past values and can show if there is a momentum factor associated with investing in Raphael Pharmaceutical.
Other Information on Investing in Raphael OTC Stock
Raphael Pharmaceutical financial ratios help investors to determine whether Raphael OTC Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Raphael with respect to the benefits of owning Raphael Pharmaceutical security.